2 Patents
- US124404872025Method of Normalizing the Neutrophil to Lymphocyte Ratio in Cancer Patients with a Selective Glucocorticoid Receptor Antagonist
Corcept Therapeutics Incorporated
0 cites - US121092722024Intermittent Dosing of Glucocorticoid Receptor Modulators for the Treatment of Ovarian and Other Cancers
Corcept Therapeutics Incorporated
0 cites